<DOC>
	<DOC>NCT01000220</DOC>
	<brief_summary>Omeprazole is a safe drug listed in OTC drug due to its safety. It acts by irreversible inhibition of K/H ATP ase pump and also Na/K ATP ase, Na/H ATP ase.Considering these actions the effect of omeprazole on decreasing intra ocular pressure is an issue of debate.In this Randomized Clinical Trial conducted in labafinejad hospital, patients with glaucoma who need to take omeprazole due to GI problem are evaluated in two groups including placebo and drug users. The effect will be finally assessed.</brief_summary>
	<brief_title>Evaluation of Omeprazole Effect on Glaucoma</brief_title>
	<detailed_description>Omeprazole is a safe drug listed in OTC drug due to its safety. It acts by irreversible inhibition of K/H ATP ase pump and also Na/K ATP ase, Na/H ATP ase.Considering these actions the effect of omeprazole on decreasing intra ocular pressure is an issue of debate.In this Randomized Clinical Trial conducted in labafinejad hospital, patients with glaucoma who need to take omeprazole due to GI problem are evaluated in two groups including placebo and drug users. The effect will be finally assessed.</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>patients with glaucoma 18 to 70 years POAG patients, Pseudoexfoliation no history of other systemic disease no history of intraocular intervention no history of H2 blocker or PPI consumption during the past month consuming 2 or less topical antiglaucoma medication no present immune deficiency no addiction habit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>